AstraZeneca & MSD Inc win EU approval for breast-cancer drug Lynparza
AstraZeneca and U.S. partner MSD Inc. have made it to the headlines for winning European…
AstraZeneca and U.S. partner MSD Inc. have made it to the headlines for winning European…
One of the world’s leading pharma company GlaxoSmithKline Plc has reportedly attained the approval of…
The partnership expansion would further support the development of rapid diagnostic assays needed for detecting…
The clinical-stage biotechnology company, Aeglea BioTherapeutics Inc., has reportedly announced positive Phase 1/2 data for…
Clinical-stage biopharmaceutical company Viking Therapeutics, Inc. will reportedly present data from its 12-week long Phase…
The two firms will focus on accelerating global development of companion tests for several oncology…
More than eight individuals treated with the SB-525 gene therapy demonstrated increases in FVIII activity…
The new drug is anticipated to be available for its commercial launch in the second…
ten3T will reportedly use the funds to expand the usability of their product called Cicer…